Why did this happen? These T-Cells target and destroy any abnormal cells, including cancer cells. The FDA is expected to review Bristol Myers Squibbs Opdivo for additional indications and Zeposia for treating ulcerative colitis. After the multiple myeloma CAR-T therapy approval, eyes will now be on the FDAs decision regarding Opdivos use for additional indications, as well as Zeposia in ulcerative colitis. That said, the recent approval marks the only approved CAR-T therapy for the treatment of multiple myeloma.
The FDA has a high A-T-carrier.
( z0 have :ARG0 ( z1 government-organization :name ( z2 name :op "FDA" ) ) :ARG1 ( z3 amr-unintelligible :ARG0-of ( z4 carry ) :ARG1-of ( z5 high ) ) )
(z0 / have-03
    :ARG0 (z1 / government-organization
              :name (z2 / name
                        :op1 "FDA"))
    :ARG1 (z3 / amr-unintelligible
              :ARG0-of (z4 / carry-01)
              :ARG1-of (z5 / high-02)))
The FDA has a high A - T - carrier .
z1 :name z2
z2 :op1 0
z0 :ARG0 z1
z3 :ARG1-of z5
z0 :ARG1 z3
z3 :ARG0-of z4